Wegovy vs Mounjaro: Which Works Better at Week 13-16?
Private Prescription Advantage: Wegovy 1.7 Equivalent to Mounjaro Access
When comparing Wegovy 1.7 equivalent to Mounjaro through private prescription UK services, the primary advantage is immediate access without NHS restrictions. The NHS route requires GP referral to specialist weight management services, with typical waiting times exceeding 6 months and strict BMI criteria. Private prescription eliminates these barriers, allowing you to continue your week 13-16 treatment schedule without interruption. EverydayMeds provides both Wegovy and Mounjaro through our GPhC-registered pharmacy (#9012878), ensuring continuity of care regardless of which medication your prescriber recommends.
The private prescription process transforms what would be a lengthy NHS journey into a streamlined experience. Your clinical assessment takes just 3 minutes, prescriber review occurs within 24-72 hours, and next-day cold-chain delivery ensures your Wegovy 1.7mg arrives safely. This efficiency is particularly crucial at the 1.7mg stage, where treatment momentum is building and any supply disruption could impact your progress. Both medications require the same clinical oversight, but private prescription offers consistent supply and flexible dosing schedules.
Wegovy 1.7mg vs Mounjaro Pricing: Transparent UK Costs
Wegovy 1.7mg costs £139.99 per pen at EverydayMeds, with returning customers applying code DOSE25 at checkout for best pricing. For those planning transition to maintenance, our Elevate Duo bundle (1.7mg + 2.4mg) provides both doses for £369.99, ensuring seamless progression. Mounjaro pricing varies by equivalent dose, but both medications represent similar monthly investment when prescribed privately. The Consistency 1.7mg bundle offers two Wegovy pens for £309.99, ideal for extended treatment at this dose level.
Private prescription costs must be weighed against NHS waiting times and access restrictions. While NHS provision is free at point of use, the 6+ month wait and stringent criteria mean many patients never access treatment. Private prescription provides immediate access to the same prescription-only medicine, manufactured by Novo Nordisk, with transparent pricing and no hidden costs. Payment includes clinical assessment, prescriber review, and next-day delivery with temperature-controlled packaging.
Clinical Evidence: Wegovy 1.7 Equivalent to Mounjaro Effectiveness
Wegovy's clinical evidence comes from the STEP trial programme, where patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021). The 1.7mg dose represents the penultimate escalation step, where therapeutic effects are approaching their peak. Mounjaro's evidence derives from different trial populations and endpoints, making direct comparison inappropriate.
Both medications require dose escalation protocols, with Wegovy 1.7mg prescribed for weeks 13-16 before advancing to 2.4mg maintenance. Clinical trials demonstrate that patients typically experience accelerating results during this phase, as the medication reaches more effective therapeutic levels. The prescription-only medicine status reflects the need for medical supervision during dose escalation.
Mechanism Differences: How Wegovy 1.7 Equivalent to Mounjaro Works
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones produced in your intestine. It may help reduce appetite by acting on brain appetite centres, promoting feeling of fullness after smaller meals, and potentially reducing food cravings. The 1.7mg dose provides enhanced receptor activation compared to earlier escalation steps, supporting more pronounced appetite control. Mounjaro (tirzepatide) works differently as a dual GIP and GLP-1 receptor agonist, targeting two hormone pathways simultaneously. Both medications must be used alongside a reduced-calorie diet and increased physical activity, as they support rather than replace lifestyle modifications.
Private Prescription Ordering: Wegovy 1.7mg Mounjaro Comparison Process
EverydayMeds' private prescription service begins with a 3-minute online clinical assessment covering medical history, current medications, and treatment goals. Your responses are reviewed by our prescribing team within standard 3 working days (express 24-hour service available), who determine suitability for Wegovy 1.7mg or recommend Mounjaro based on individual factors. Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy and dispatched via next-day delivery with cold-chain packaging. The process requires no GP referral and operates independently of NHS services, providing consistent access regardless of local commissioning decisions. Temperature monitoring ensures your medication arrives within the required 2-8°C range for optimal efficacy.
Storage and Practical Considerations: Wegovy vs Mounjaro Advantages
Wegovy offers significant storage advantages over Mounjaro, remaining stable at room temperature for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day limit. This makes Wegovy 1.7mg more suitable for frequent travellers or those with limited refrigerator space. The FlexTouch pen delivery system provides precise 1.7mg dosing with an easy-to-use click mechanism and dose counter. Both medications require weekly injection, but Wegovy's extended room temperature stability reduces storage anxiety and travel planning complexity. The pen should be stored in original packaging to protect from light and never frozen or shaken vigorously.
Week 13-16 Treatment Planning: Wegovy 1.7 Equivalent to Mounjaro Transitions
The 1.7mg stage represents a critical transition point where patients often notice accelerated results and begin planning long-term maintenance strategies. Private prescription allows flexible timing for progression to 2.4mg maintenance, avoiding NHS appointment scheduling constraints. Many patients at this stage benefit from our Elevate Duo bundle, providing both 1.7mg and 2.4mg doses for seamless transition. The prescription-only medicine status ensures medical oversight during this crucial escalation phase.
Comparing Wegovy 1.7 equivalent to Mounjaro at this stage involves considering individual response patterns, side effect profiles, and long-term treatment goals. Some patients find Wegovy's single-pathway mechanism sufficient, while others may benefit from Mounjaro's dual-receptor approach. Private prescription allows switching between medications if initial choice proves suboptimal, providing treatment flexibility unavailable through NHS services.
Secure Your Wegovy 1.7mg Supply: Private Prescription Benefits
Ready to continue your weight management journey without NHS delays? Visit https://everydaymeds.co.uk/products/wegovy-1-7mg to begin your clinical assessment for Wegovy 1.7mg at £139.99. Returning customers can use code DOSE25 at checkout for optimal pricing, while the Elevate Duo bundle prepares you for maintenance transition. Our GPhC-registered pharmacy (#9012878) ensures consistent supply of this prescription-only medicine with next-day delivery across the UK. The streamlined private prescription process means no waiting lists, no GP referral requirements, and no supply uncertainties - just reliable access to your chosen treatment. Both Wegovy and Mounjaro are available through our service, with expert prescriber guidance to determine the most suitable option for your individual circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
